Showing 191-200 of 5608 results for "".
VISUMAX® 800: Redefining Refractive Surgery With Unmatched Speed and Comfort
https://crstoday.com/crst-supplements/visumax-800-redefining-refractive-surgery-with-unmatched-speed-and-comfort/visumax-800-redefining-refractive-surgery-with-unmatched-speed-and-comfort/45282/Excerpts from a symposium held during the 2024 Caribbean Eye MeetingWhy We Are Waiting to Adopt Laser Cataract Surgery
https://crstoday.com/topics/general/why-we-are-waiting-to-adopt-laser-cataract-surgery/42353/We will be watching from the sidelines for a few more months.A New Model for DED Recognition, Prevention, and Treatment?
https://crstoday.com/topics/general/a-new-model-for-ded-recognition-prevention-and-treatment/43086/Ophthalmologists can take a page from dentists.New Technologies I’m Using in 2021
https://crstoday.com/crst-issues/april-2021/new-technologies-im-using-in-2021/44434/Surgeons from around the world share their latest practice additions.The Origins of Laser Cataract Surgery
https://crstoday.com/topics/general/the-origins-of-laser-cataract-surgery/42096/Three companies' pathways from development to commercialization.Nonalcohol LASEK Retreatments
https://crstoday.com/crst-issues/2005-jan/0105_muravchik-html/40899/Postoperative complications from conventional refractive surgery may be lessened with this procedure.AI-Powered Cataract Surgical Planning
https://crstoday.com/crst-issues/jan-2026/ai-powered-cataract-surgical-planning/54540/From IOL calculators to digital copilots.Winning Practice Models
https://crstoday.com/crst-issues/nov-dec-2021/winning-practice-models/44595/Tips from three practices that have added elective services successfully to grow their practices.LASIK: Wavefront-Guided Versus Wavefront - Optimized Technology
https://crstoday.com/topics/general/lasikwavefront-guided-versus-wavefront-optimized-technology/41996/Results from the Stanford University study on excimer laser surgery.Q&A With Glaukos CEO Thomas Burns
https://crstoday.com/topics/general/qa-with-glaukos-ceo-thomas-burns/42888/The process of validating a new category in glaucoma and transitioning from a startup to a public company.